Cerus Corporation (NASDAQ: CERS) announced U.S. Food and Drug Administration (FDA) approval of the INTERCEPT Blood System for treatment of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE